Folgen
Jan Alsner
Jan Alsner
Bestätigte E-Mail-Adresse bei oncology.au.dk
Titel
Zitiert von
Zitiert von
Jahr
Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck
P Lassen, JG Eriksen, S Hamilton-Dutoit, T Tramm, J Alsner, J Overgaard
J Clin Oncol 27 (12), 1992-1998, 2009
6932009
The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis
J Bartkova, J Lukas, P Guldberg, J Alsner, AF Kirkin, J Zeuthen, J Bartek
Cancer Research 56 (23), 5475-5483, 1996
3741996
FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial
LS Mortensen, J Johansen, J Kallehauge, H Primdahl, M Busk, P Lassen, ...
Radiotherapy and oncology 105 (1), 14-20, 2012
3042012
Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind …
J Overgaard, JG Eriksen, M Nordsmark, J Alsner, MR Horsman
The lancet oncology 6 (10), 757-764, 2005
2862005
Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations
M Nordsmark, J Alsner, J Keller, OS Nielsen, OM Jensen, MR Horsman, ...
British Journal of Cancer 84 (8), 1070-1075, 2001
2712001
Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes
CN Andreassen, J Alsner, M Overgaard, J Overgaard
Radiotherapy and Oncology 69 (2), 127-135, 2003
2562003
Development of a hypoxia gene expression classifier with predictive impact for hypoxic modification of radiotherapy in head and neck cancer
K Toustrup, BS Sørensen, M Nordsmark, M Busk, C Wiuf, J Alsner, ...
Cancer research 71 (17), 5923-5931, 2011
2412011
A technical assessment of the utility of reverse phase protein arrays for the study of the functional proteome in non-microdissected human breast cancers
BT Hennessy, Y Lu, AM Gonzalez-Angulo, MS Carey, S Myhre, Z Ju, ...
Clinical proteomics 6 (4), 129-151, 2010
2392010
Does variability in normal tissue reactions after radiotherapy have a genetic basis–where and how to look for it?
CN Andreassen, J Alsner, J Overgaard
Radiotherapy and Oncology 64 (2), 131-140, 2002
2352002
HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer
P Lassen, JG Eriksen, S Hamilton-Dutoit, T Tramm, J Alsner, J Overgaard
Radiotherapy and Oncology 94 (1), 30-35, 2010
2222010
Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck
K Toustrup, BS Sørensen, P Lassen, C Wiuf, J Alsner, J Overgaard
Radiotherapy and Oncology 102 (1), 122-129, 2012
2042012
Genetic variants and normal tissue toxicity after radiotherapy: a systematic review
CN Andreassen, J Alsner
Radiotherapy and oncology 92 (3), 299-309, 2009
1972009
Establishment of a radiogenomics consortium
C West, BS Rosenstein, J Alsner, D Azria, G Barnett, A Begg, S Bentzen, ...
International Journal of Radiation Oncology Biology Physics 76 (5), 1295-1296, 2010
1792010
Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer
R Agarwal, AM Gonzalez-Angulo, S Myhre, M Carey, JS Lee, J Overgaard, ...
Clinical cancer research 15 (11), 3654-3662, 2009
1682009
Activation of peroxisome proliferator-activated receptor γ bypasses the function of the retinoblastoma protein in adipocyte differentiation
JB Hansen, RK Petersen, BM Larsen, J Bartkova, J Alsner, K Kristiansen
Journal of Biological Chemistry 274 (4), 2386-2393, 1999
1611999
Camptothecin-stabilized topoisomerase I-DNA adducts cause premature termination of transcription
C Bendixen, B Thomsen, J Alsner, O Westergaard
Biochemistry 29 (23), 5613-5619, 1990
1611990
Mode of action of topoisomerase II-targeting agents at a specific DNA sequence: uncoupling the DNA binding, cleavage and religation events
BS Sørensen, J Sinding, AH Andersen, J Alsner, PB Jensen, ...
Journal of molecular biology 228 (3), 778-786, 1992
1541992
TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer
CN Andreassen, J Alsner, J Overgaard, C Herskind, J Haviland, R Owen, ...
Radiotherapy and oncology 75 (1), 18-21, 2005
1472005
The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the …
JG Eriksen, T Steiniche, J Askaa, J Alsner, J Overgaard
International Journal of Radiation Oncology* Biology* Physics 58 (2), 561-566, 2004
1412004
Genetic markers for prediction of normal tissue toxicity after radiotherapy
J Alsner, CN Andreassen, J Overgaard
Seminars in radiation oncology 18 (2), 126-135, 2008
1352008
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20